depression

  1. Andy

    Altered Tryptophan Metabolism on the Kynurenine Pathway in Depressive Patients with Small Intestinal Bacterial Overgrowth, 2022, Chojnacki et al

    Abstract The causes of depression are diverse and are still not fully understood. Recently, an increasing role is attributed to nutritional and inflammatory factors. The aim of this study was to evaluate selected metabolites of the tryptophan kynurenine pathway in depressive patients with small...
  2. Andy

    Predictors of “brain fog” 1 year after COVID-19 disease, 2022, Cristillo et al

    Abstract Introduction Brain fog has been described up to 1 year after SARS-CoV-2 infection, notwithstanding the underlying mechanisms are still poorly investigated. In this study, we aimed to evaluate the prevalence of cognitive complaints at 1-year follow-up and to identify the factors related...
  3. Wyva

    The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients, 2022, Goulabchand et al

    Abstract Primary Sjögren’s syndrome (pSS) is an autoimmune disease with frequent neurological involvement. Memory complaints are common, but their precise patterns remain unclear. We wanted to characterize patterns of neurocognitive profiles in pSS patients with cognitive complaints. Only pSS...
  4. cassava7

    Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain…, Howard et al, 2019

    Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions Major depression is a debilitating psychiatric illness that is typically associated with low mood and anhedonia. Depression has a heritable component that...
  5. cassava7

    The serotonin theory of depression: a systematic umbrella review of the evidence, Moncrieff et al, 2022

    Joanna Moncrieff, Ruth E. Cooper, Tom Stockmann, Simone Amendola, Michael P. Hengartner & Mark A. Horowitz The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or...
  6. Dolphin

    Antidepressant withdrawal syndrome and its management (slide presentation), 2022, Horowitz

    Slide presentation: "Antidepressant withdrawal syndrome and its management" Dr Mark Horowitz BA, BSc, MBBS, MSc, PhD (IoPPN, KCL) Clinical Research Fellow on RADAR trial (UCL, NELFT) Psychiatry Trainee (Camden & Islington) m.horowitz@ucl.ac.uk...
  7. Andy

    The mediating role of anxiety/depression symptoms between adverse childhood experiences (ACEs) and somatic symptoms in adolescents, 2022, Lee et al

    Abstract Introduction This study examines the relationships among recent adverse childhood experiences (ACEs), somatic symptoms, and anxiety/depression symptoms during adolescence and whether anxiety/depression symptoms mediate the relationship between ACEs and somatic symptoms. Methods...
  8. Dolphin

    Infectious mononucleosis as a risk factor for depression: A nationwide cohort study, 2021, Vindegaard et al

    I wonder whether ME/CFS would be a better primary diagnosis for some of these people? https://www.sciencedirect.com/science/article/abs/pii/S0889159121000398 Brain, Behavior, and Immunity Volume 94, May 2021, Pages 259-265 Infectious mononucleosis as a risk factor for depression: A nationwide...
  9. Wyva

    Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae, 2022, Su et al

    Highlights Longitudinal multiomics associate PASC with autoantibodies, viremia and comorbidities Reactivation of latent viruses during initial infection may contribute to PASC Subclinical autoantibodies negatively correlate with anti-SARS-CoV-2 antibodies Gastrointestinal PASC uniquely present...
  10. Sly Saint

    Blog Psychology today: Differentiating Fibromyalgia, Depression, and CFS

    https://www.psychologytoday.com/gb/blog/happiness-is-state-mind/202112/differentiating-fibromyalgia-depression-and-cfs I didn't read any further because if they still haven't got to grips with the diagnostic criteria.......
  11. rvallee

    What treatments work for anxiety and depression in children and adolescents with [CFS]? An updated systematic review, 2021, Clery et al

    (Embargoed until 2099?) Oxford criteria, so tagged as "chronic fatigue", not applicable to ME/CFS. Philippa Clery*, Alexander Royston , Katie Driver, Jasmine Bailey, Esther M Crawley, Maria Loades...
  12. O

    Do Anxiety and Depression Predict Persistent Physical Symptoms After a Severe COVID-19 Episode? A Prospective Study, 2021, Bottemanne et al

    Background: Persistent physical symptoms are common after a coronavirus disease 2019 (COVID-19) episode, but their pathophysiological mechanisms remain poorly understood. In this study, we aimed to explore the association between anxiety and depression at 1-month after acute infection and the...
  13. Andy

    Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders, 2021, Van Overmeire et al

    ABSTRACT Background Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia. Aim To investigate on the one hand the global sexual desire, the dyadic sexual and...
  14. Andy

    UK: Guardian: "NHS to give therapy for depression before medication under new guidelines"

    "Millions of people with mild depression in England should be offered therapy, exercise, mindfulness or meditation before antidepressants, according to the first new NHS guidelines in more than a decade. Under draft guidance, the National Institute for Health and Care Excellence (Nice)...
  15. Andy

    Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity, 2021, Han et al

    Abstract Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recurrent symptoms of abdominal pain and irregular defecation. Changed gut microbiota has been proposed to mediate IBS; however, contradictory results exist, and...
  16. Sly Saint

    Do adolescents w/CFS/ME & co-morbid anxiety &/or depressive symptoms think differently to those who do not have co-morbid psychopathology?,2020,Loades

    Do adolescents with chronic fatigue syndrome (CFS/ME) and co-morbid anxiety and/or depressive symptoms think differently to those who do not have co-morbid psychopathology? 2020 Loades, Crawley et al Abstract Background Co-morbid anxiety and/or depression is common in adolescents with Chronic...
  17. rvallee

    Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults, 2021, Jones et al

    A Systematic Review and Meta-analysis Key Points Question What is the placebo effect magnitude in different treatment modalities used for management of patients with treatment-resistant depression? Findings In this systematic review and meta-analysis of 3228 patients with...
  18. ME/CFS Skeptic

    Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy..., 2014, Mohr et al.

    Abstract Control conditions are the primary methodology used to reduce threats to internal validity in randomized controlled trials (RCTs). This meta-analysis examined the effects of control arm design and implementation on outcomes in RCTs examining psychological treatments for depression. A...
  19. Woolie

    Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder, 2015, Berger

    Full reference: Berger, D. (2015). Double-blinding and bias in medication and cognitive-behavioral therapy trials for major depressive disorder. F1000Research, 4. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/ Abstract:
  20. Woolie

    Active placebos versus antidepressants for depression, 2004, Moncrieff, Wessely, Hardy

    Just came across this and thought it might be of interest (its not new, its from 2004) Moncrieff, J., Wessely, S., & Hardy, R. (2004). Active placebos versus antidepressants for depression. Cochrane database of systematic reviews, CD003012.PUB2...
Back
Top Bottom